Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Oncogene
|
October 31, 2007
A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion
S Tsutsumi, B Scroggins, F Koga, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
April 9, 2002
Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression
Q Q Li, M K Yunmbam, X Zhong, et al.
Current Topics in Medicinal Chemistry
|
October 29, 2009
Update on Hsp90 inhibitors in clinical trial
Y S Kim, S V Alarcon, S Lee, et al.
FEBS Letters
|
October 19, 1987
Site-selective cyclic AMP analogs provide a new approach in the control of cancer cell growth
D Katsaros, G Tortora, P Tagliaferri, et al.
Biochemical Pharmacology
|
September 29, 2000
Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors
E G Mimnaugh, M K Yunmbam, Q Li, et al.
Cancer Research
|
January 1, 1997
Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death
M V Blagosklonny, P Giannakakou, W S el-Deiry, et al.
Blood
|
July 15, 1996
Electroporation of synthetic oligodeoxynucleotides: a novel technique for ex vivo bone marrow purging
R Bergan, F Hakim, G N Schwartz, et al.
Blood
|
November 15, 1989
Gamma/delta lineage relationship within a consecutive series of human precursor T-cell neoplasms
J P de Villartay, A B Pullman, R Andrade, et al.
The Journal of Biological Chemistry
|
March 1, 1996
p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2
C Chavany, E Mimnaugh, P Miller, et al.
Leukemia
|
September 14, 2007
FLT3 regulates beta-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cells
T Kajiguchi, E J Chung, S Lee, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Oncogene
|
October 31, 2007
A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion
S Tsutsumi, B Scroggins, F Koga, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
April 9, 2002
Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression
Q Q Li, M K Yunmbam, X Zhong, et al.
Current Topics in Medicinal Chemistry
|
October 29, 2009
Update on Hsp90 inhibitors in clinical trial
Y S Kim, S V Alarcon, S Lee, et al.
FEBS Letters
|
October 19, 1987
Site-selective cyclic AMP analogs provide a new approach in the control of cancer cell growth
D Katsaros, G Tortora, P Tagliaferri, et al.
Biochemical Pharmacology
|
September 29, 2000
Prevention of cisplatin-DNA adduct repair and potentiation of cisplatin-induced apoptosis in ovarian carcinoma cells by proteasome inhibitors
E G Mimnaugh, M K Yunmbam, Q Li, et al.
Cancer Research
|
January 1, 1997
Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death
M V Blagosklonny, P Giannakakou, W S el-Deiry, et al.
Blood
|
July 15, 1996
Electroporation of synthetic oligodeoxynucleotides: a novel technique for ex vivo bone marrow purging
R Bergan, F Hakim, G N Schwartz, et al.
Blood
|
November 15, 1989
Gamma/delta lineage relationship within a consecutive series of human precursor T-cell neoplasms
J P de Villartay, A B Pullman, R Andrade, et al.
The Journal of Biological Chemistry
|
March 1, 1996
p185erbB2 binds to GRP94 in vivo. Dissociation of the p185erbB2/GRP94 heterocomplex by benzoquinone ansamycins precedes depletion of p185erbB2
C Chavany, E Mimnaugh, P Miller, et al.
Leukemia
|
September 14, 2007
FLT3 regulates beta-catenin tyrosine phosphorylation, nuclear localization, and transcriptional activity in acute myeloid leukemia cells
T Kajiguchi, E J Chung, S Lee, et al.
Page
of 6